| |
| |
|
| Insider
Information: |
Garg Vipin K |
| Relationship: |
President and CEO, Dir... |
| City: |
Durham |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
452,776 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,377,990 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
452,776 |
|
|
| Total
Value |
$2,377,990 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Neos Therapeutics, Inc. |
NEOS |
Chief Executive Officer |
2018-03-01 |
160,748 |
|
0 |
Premium* |
|
|
Altimmune, Inc |
ALT |
President and CEO, Dir... |
2024-02-02 |
292,028 |
2018-11-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
63 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALT |
Altimmune, Inc |
President and CEO |
• • – |
2022-11-30 |
4 |
D |
$9.95 |
$29,920 |
D/D |
(3,007) |
227,775 |
0 |
- |
|
| ALT |
Altimmune, Inc |
President and CEO |
• • – |
2023-02-01 |
4 |
D |
$13.78 |
$105,527 |
D/D |
(7,658) |
238,601 |
0 |
- |
|
| ALT |
Altimmune, Inc |
President and CEO |
• • – |
2023-02-02 |
4 |
D |
$15.04 |
$126,667 |
D/D |
(8,422) |
249,129 |
0 |
- |
|
| ALT |
Altimmune, Inc |
President and CEO |
• • – |
2024-01-30 |
4 |
D |
$9.80 |
$114,631 |
D/D |
(11,697) |
264,333 |
0 |
- |
|
| ALT |
Altimmune, Inc |
President and CEO |
• • – |
2024-02-01 |
4 |
D |
$9.88 |
$72,252 |
D/D |
(7,313) |
281,454 |
0 |
- |
|
| ALT |
Altimmune, Inc |
President and CEO |
• • – |
2024-02-02 |
4 |
D |
$9.32 |
$78,064 |
D/D |
(8,376) |
292,028 |
0 |
- |
|
| NEOS |
Neos Therapeutics, Inc. |
Chief Executive OfficerOfficer |
• • – |
2015-07-22 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
142,049 |
|
- |
|
| ALT |
Altimmune, Inc |
President and CEO |
• • – |
2022-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,545 |
300,503 |
0 |
- |
|
| ALT |
Altimmune, Inc |
President and CEO |
• • – |
2023-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,546 |
246,259 |
0 |
- |
|
| ALT |
Altimmune, Inc |
President and CEO |
• • – |
2023-02-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,950 |
257,551 |
0 |
- |
|
| ALT |
Altimmune, Inc |
President and CEO |
• • – |
2024-01-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
26,775 |
276,030 |
0 |
- |
|
| ALT |
Altimmune, Inc |
President and CEO |
• • – |
2024-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,545 |
288,767 |
0 |
- |
|
| ALT |
Altimmune, Inc |
President and CEO |
• • – |
2024-02-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,950 |
300,404 |
0 |
- |
|
63 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
